⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19608704 | 1.00 | — | — | |
| SCHEMBL5713342 | 0.79 | NOS1 (0.34) | — | |
| SCHEMBL174399 | 0.79 | — | — | |
| SCHEMBL6022879 | 0.77 | — | — | |
| Bromide SCHEMBL27878723 | 0.77 | — | — | |
| SCHEMBL23666770 | 0.75 | — | — | |
| SCHEMBL3477581 | 0.75 | — | — | |
| SCHEMBL9963226 | 0.75 | NOS1 (0.32) | — | |
| SCHEMBL508211 | 0.75 | — | — | |
| SCHEMBL11152177 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219986-A1 | NOVEL AMINOPYRIMIDINE EGFR INHIBITOR | QILU PHARMACEUTICAL CO., LTD. (CN) | 2023-07-13 | — | — | US | disclosed |